XML 15 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Net sales $ 493,842 $ 462,274 $ 1,420,156 $ 1,395,600
Cost of goods sold (excluding amortization expense - See Note 13) 312,977 289,725 906,308 865,770
Gross profit 180,865 172,549 513,848 529,830
Selling, general and administrative expenses 126,479 118,221 372,125 359,350
Impairment charges 0 0 88,840 0
Restructuring and related charges, net 7,745 2,610 31,128 4,787
Operating income 46,641 51,718 21,755 165,693
Other (expense) income, net (270) 783 (1,632) 2,285
Interest expense (10,941) (10,347) (33,265) (31,925)
Income (loss) before taxes and equity in net income of associated companies 35,430 42,154 (13,142) 136,053
Taxes on income before equity in net income of associated companies 9,266 12,167 22,280 40,453
Income (loss) before equity in net income of associated companies 26,164 29,987 (35,422) 95,600
Equity in net income of associated companies 4,322 2,385 12,262 6,940
Net income (loss) 30,486 32,372 (23,160) 102,540
Less: Net income attributable to noncontrolling interest 17 26 29 82
Net income (loss) attributable to Quaker Chemical Corporation $ 30,469 $ 32,346 $ (23,189) $ 102,458
Per share data:        
Net income attributable to Quaker Chemical Corporation common shareholders – basic (in dollars per share) $ 1.75 $ 1.81 $ (1.32) $ 5.71
Net income attributable to Quaker Chemical Corporation common shareholders – diluted (in dollars per share) 1.75 1.81 (1.32) 5.70
Dividends declared (in dollars per share) $ 0.508 $ 0.485 $ 1.478 $ 1.395